Halozyme Therapeutics competitorsClear all

Agenus's top competitors include Karyopharm Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Agenus
Agenus
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Founding Date
Founding Date
1994
Founding Date
2008
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Lexington, US HQ
Cambridge, GB
Berkeley, US
New York, US
Locations
Newton, US HQ
München, DE
Giv'atayim, IL
Providence, US
Employees
Employees
32812% increase
Employees
481
Alexa Website Rank
Alexa Website Rank
479547
Alexa Website Rank
230559
Employee Rating
Employee Rating
3.2
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$88.2m (FY, 2020)
Revenue (est.)
$108.1m (FY, 2020)
Net income
Net income
($182.9m) (FY, 2020)
Net income
($196.3m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 171.1m
Total funding raised
$ 248.7m
For sources of this data, please see the company profile

View company profiles

Karyopharm Therapeutics
HQ
Newton, US

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

View company